XBIO

Xenetic Biosciences Inc. Common Stock (XBIO)

Stock · NASDAQ · Health Care

$3.98as of 8/28/2026

Active signals

High Beta54.2%
Support level
$2.96
Industry
Biotechnology: Pharmaceutical Preparations

How Xenetic Biosciences Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$2.98MR&D$3.07M (103%)SG&A$2.75M (92%)XBIO

Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub

Xenetic Biosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • XBIO
    Xenetic Biosciences Inc. Common Stock
    $3.98
    ▲ 1.66%
    Market cap $6.53MP/E
  • ALZN
    Alzamend Neuro Inc. Common Stock
    $1.66
    ▼ 0.30%
    Market cap $6.61MP/E
    $0.84$2.68
  • IMNN
    Imunon Inc. Common Stock
    $1.58
    ▼ 1.25%
    Market cap $6.64MP/E
    $1.47$6.39
  • ACXP
    Acurx Pharmaceuticals Inc. Common Stock
    $1.45
    ▼ 1.03%
    Market cap $6.27MP/E
    $1.31$8.34
  • HCWB
    HCW Biologics Inc. Common Stock
    $3.39
    ▲ 6.94%
    Market cap $6.19MP/E
    $1.5$38.16
  • APVO
    Aptevo Therapeutics Inc. Common Stock
    $2.36
    ▼ 2.48%
    Market cap $6.18MP/E 0.00
    $2.3$48.78
  • PULM
    Pulmatrix Inc. Common Stock
    $1.51
    ▼ 0.66%
    Market cap $6.06MP/E
    $1.16$5.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
169.1K
Total value held
$446.0K
Institutional holders
6
Top holders this quarter
  • Unknown137.4K
  • Unknown21.4K
  • Unknown6.7K
  • Unknown2.7K
  • Unknown806
  • Unknown2

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.